Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1397962 | 0.84 | — | — | |
| Crotonic Acid SCHEMBL5827875 | 0.83 | — | — | |
| Acrylic Acid SCHEMBL2060165 | 0.83 | LMNA (0.31) | LMNAALOX15HSD17B10 | |
| Methacrylic Acid SCHEMBL5828781 | 0.83 | — | — | |
| SCHEMBL4059135 | 0.76 | TSHR (0.34) | HSD17B10 | |
| SCHEMBL9885396 | 0.73 | TSHR (0.39) | HSD17B10 | |
| SCHEMBL17583235 | 0.72 | — | — | |
| Acrylic Acid SCHEMBL30656955 | 0.72 | LMNA (0.30) | LMNA | |
| Acrylic Acid SCHEMBL29894437 | 0.71 | LMNA (0.43) | LMNAALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL29393593 | 0.71 | LMNA (0.43) | LMNAALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441828-B2 | Radiation-curable composition for use in rapid prototyping or rapid manufacturing methods | KULZER GMBH (DE) | 2025-10-14 | — | — | US | claimed |
| US-12187833-B2 | Radiation-curable composition for use in rapid prototyping or rapid manufacturing methods | KULZER GMBH (DE) | 2025-01-07 | — | — | US | claimed |
| US-20240317918-A1 | RADIATION-CURABLE COMPOSITION FOR USE IN RAPID PROTOTYPING OR RAPID MANUFACTURING METHODS | KULZER GMBH (DE) | 2024-09-26 | — | — | US | claimed |
| US-11939414-B2 | Radiation-curable composition for use in rapid prototyping or rapid manufacturing methods | KULZER GMBH (DE) | 2024-03-26 | — | — | US | claimed |
| CN-113677718-B | Radiation curable compositions for rapid prototyping or rapid manufacturing processes | 古莎有限公司 | 2023-12-01 | — | — | CN | claimed |
| US-20220177631-A1 | RADIATION-CURABLE COMPOSITION FOR USE IN RAPID PROTOTYPING OR RAPID MANUFACTURING METHODS | KULZER GMBH (DE) | 2022-06-09 | — | — | US | claimed |
| US-20220162370-A1 | RADIATION-CURABLE COMPOSITION FOR USE IN RAPID PROTOTYPING OR RAPID MANUFACTURING METHODS | KULZER GMBH (DE) | 2022-05-26 | — | — | US | claimed |
| EP-3923853-A1 | RADIATION-CURABLE COMPOSITION FOR USE IN RAPID PROTOTYPING OR RAPID MANUFACTURING METHODS | Kulzer GmbH (DE) | 2021-12-22 | — | — | EP | claimed |
| WO-2020182810-A1 | RADIATION-CURABLE COMPOSITION FOR USE IN RAPID PROTOTYPING OR RAPID MANUFACTURING METHODS | KULZER GMBH (DE) | 2020-09-17 | — | — | WO | claimed |
| US-7067584-B2 | Solvent-containing coating material and the use thereof | BASF COATINGS AG (DE) | 2006-06-27 | — | — | US | claimed |
| US-20040019142-A1 | Solvent-containing coating material and the use thereof | RINK HEINZ-PETER (DE) | 2004-01-29 | — | — | US | claimed |
| US-12441828-B2 | Radiation-curable composition for use in rapid prototyping or rapid manufacturing methods | KULZER GMBH (DE) | 2025-10-14 | — | — | US | disclosed |
| US-12187833-B2 | Radiation-curable composition for use in rapid prototyping or rapid manufacturing methods | KULZER GMBH (DE) | 2025-01-07 | — | — | US | disclosed |
| US-20240317918-A1 | RADIATION-CURABLE COMPOSITION FOR USE IN RAPID PROTOTYPING OR RAPID MANUFACTURING METHODS | KULZER GMBH (DE) | 2024-09-26 | — | — | US | disclosed |
| US-11939414-B2 | Radiation-curable composition for use in rapid prototyping or rapid manufacturing methods | KULZER GMBH (DE) | 2024-03-26 | — | — | US | disclosed |
| US-6706333-B2 | Using an aqueous dispersion of a copolymer of an olefinically unsaturated monomer and at least one olefinically unsaturated hydrocarbon and dye/pigment for coil coating metals; paints; quality; optical properties; | BASF COATINGS AG (DE) | 2004-03-16 | — | — | US | disclosed |
| US-20040048968-A1 | Aqueous primary dispersion, substantially or completely devoid of volatile organic substances, method for the production thereof and use of the same | BASF COATINGS AKTIENGESELLSCHAFT (DE) | 2004-03-11 | — | — | US | disclosed |
| US-20030162888-A1 | Aqueous coating substances for imparting a colour and/or effect and use thereof for producing deformable laminates for imparting a colour effect and/or effect | BASF COATINGS AKTIENGESELLSCHAFT (DE) | 2003-08-28 | — | — | US | disclosed |
| US-20030143414-A1 | Aqueous primary dispersions and coating agents, methods for producing them and their use | BENDIX MAXIMILIAN (DE) | 2003-07-31 | — | — | US | disclosed |
| US-20030100673-A1 | Aqueous primary dispersions, method for preparation and use thereof | BASF COATINGS AKTIENGESELLSCHAFT (DE) | 2003-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220177631-A1 | RADIATION-CURABLE COMPOSITION FOR USE IN RAPID PROTOTYPING OR RAPID MANUFACTURING METHODS | REV1, PML, AP3M1 | LMNA 1073/4885ALOX15 2229/4885HSD17B10 3477/4885 |
| US-12441828-B2 | Radiation-curable composition for use in rapid prototyping or rapid manufacturing methods | REV1, PML, AP3M1 | LMNA 1073/4885ALOX15 2229/4885HSD17B10 3477/4885 |
| US-20240317918-A1 | RADIATION-CURABLE COMPOSITION FOR USE IN RAPID PROTOTYPING OR RAPID MANUFACTURING METHODS | REV1, CCT3, PML | LMNA 1010/4885ALOX15 2264/4885HSD17B10 3518/4885 |
| US-11939414-B2 | Radiation-curable composition for use in rapid prototyping or rapid manufacturing methods | REV1, AP3M1, CCT3 | LMNA 994/4885ALOX15 2165/4885HSD17B10 3453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.